Bio-Techne Corporation (TECH)
USD 48.33
(-3.29%)
USD 48.33
(-3.29%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 419.53 Million USD | -7.79% |
| 2023 | 454.96 Million USD | 39.57% |
| 2022 | 325.97 Million USD | -22.49% |
| 2021 | 420.55 Million USD | -2.99% |
| 2020 | 433.52 Million USD | -14.18% |
| 2019 | 505.16 Million USD | 49.01% |
| 2018 | 339 Million USD | -3.12% |
| 2017 | 349.9 Million USD | 161.59% |
| 2016 | 133.75 Million USD | 15.26% |
| 2015 | 116.04 Million USD | 796.4% |
| 2014 | 12.94 Million USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | -100.0% |
| 2006 | 13.42 Million USD | -8.13% |
| 2005 | 14.61 Million USD | -7.83% |
| 2004 | 15.85 Million USD | -7.19% |
| 2003 | 17.08 Million USD | -5.34% |
| 2002 | 18.05 Million USD | -4.67% |
| 2001 | 18.93 Million USD | -4.17% |
| 2000 | 19.75 Million USD | 0.0% |
| 1999 | - USD | 0.0% |
| 1998 | - USD | 0.0% |
| 1997 | - USD | 0.0% |
| 1996 | - USD | 0.0% |
| 1995 | - USD | 0.0% |
| 1994 | - USD | 0.0% |
| 1993 | - USD | -100.0% |
| 1992 | 2.1 Million USD | 162.5% |
| 1991 | 800 Thousand USD | -27.27% |
| 1990 | 1.1 Million USD | 83.33% |
| 1989 | 600 Thousand USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q4 | 419.53 Million USD | -15.2% |
| 2024 FY | 419.53 Million USD | -7.79% |
| 2024 Q2 | 555.69 Million USD | 1.12% |
| 2024 Q1 | 549.53 Million USD | 20.79% |
| 2024 Q3 | 494.73 Million USD | -10.97% |
| 2023 Q4 | 454.96 Million USD | -4.01% |
| 2023 FY | 454.96 Million USD | 39.57% |
| 2023 Q2 | 289.15 Million USD | -15.34% |
| 2023 Q3 | 473.99 Million USD | 63.92% |
| 2023 Q1 | 341.53 Million USD | 4.77% |
| 2022 Q2 | 351.64 Million USD | -6.8% |
| 2022 Q1 | 377.28 Million USD | -10.29% |
| 2022 FY | 325.97 Million USD | -22.49% |
| 2022 Q4 | 325.97 Million USD | -0.38% |
| 2022 Q3 | 327.22 Million USD | -6.94% |
| 2021 Q4 | 420.55 Million USD | 43.7% |
| 2021 Q1 | 399.02 Million USD | -7.96% |
| 2021 FY | 420.55 Million USD | -2.99% |
| 2021 Q2 | 305.11 Million USD | -23.53% |
| 2021 Q3 | 292.66 Million USD | -4.08% |
| 2020 Q4 | 433.52 Million USD | -13.1% |
| 2020 FY | 433.52 Million USD | -14.18% |
| 2020 Q2 | 464.04 Million USD | -18.33% |
| 2020 Q1 | 568.18 Million USD | 12.48% |
| 2020 Q3 | 498.88 Million USD | 7.51% |
| 2019 FY | 505.16 Million USD | 49.01% |
| 2019 Q2 | 545.36 Million USD | -2.87% |
| 2019 Q3 | 522.26 Million USD | -4.24% |
| 2019 Q1 | 561.47 Million USD | 65.63% |
| 2019 Q4 | 505.16 Million USD | -3.28% |
| 2018 Q2 | 362.5 Million USD | 7.41% |
| 2018 Q4 | 339 Million USD | -13.63% |
| 2018 Q1 | 337.5 Million USD | -3.54% |
| 2018 FY | 339 Million USD | -3.12% |
| 2018 Q3 | 392.5 Million USD | 8.28% |
| 2017 Q1 | 379.68 Million USD | 183.85% |
| 2017 Q2 | 347.25 Million USD | -8.54% |
| 2017 Q3 | 358.21 Million USD | 3.16% |
| 2017 Q4 | 349.9 Million USD | -2.32% |
| 2017 FY | 349.9 Million USD | 161.59% |
| 2016 Q4 | 133.75 Million USD | -17.24% |
| 2016 Q3 | 161.61 Million USD | -2.98% |
| 2016 Q2 | 166.57 Million USD | -0.99% |
| 2016 Q1 | 168.23 Million USD | 44.97% |
| 2016 FY | 133.75 Million USD | 15.26% |
| 2015 Q2 | 192.01 Million USD | 53.68% |
| 2015 FY | 116.04 Million USD | 796.4% |
| 2015 Q1 | 124.94 Million USD | 865.13% |
| 2015 Q3 | 190.01 Million USD | -1.04% |
| 2015 Q4 | 116.04 Million USD | -38.93% |
| 2014 Q4 | 12.94 Million USD | 0.0% |
| 2014 FY | 12.94 Million USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2013 Q3 | 7.43 Million USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q4 | - USD | -100.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2007 Q1 | 13.13 Million USD | -2.17% |
| 2007 Q2 | - USD | -100.0% |
| 2007 FY | - USD | -100.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2006 Q2 | 14.01 Million USD | -2.08% |
| 2006 Q3 | 13.71 Million USD | -2.13% |
| 2006 Q4 | 13.42 Million USD | -2.13% |
| 2006 FY | 13.42 Million USD | -8.13% |
| 2006 Q1 | 14.31 Million USD | -2.05% |
| 2005 Q1 | 15.54 Million USD | -1.98% |
| 2005 FY | 14.61 Million USD | -7.83% |
| 2005 Q3 | 14.91 Million USD | -2.04% |
| 2005 Q2 | 15.22 Million USD | -2.02% |
| 2005 Q4 | 14.61 Million USD | -2.02% |
| 2004 FY | 15.85 Million USD | -7.19% |
| 2004 Q3 | 16.16 Million USD | -1.88% |
| 2004 Q2 | 16.47 Million USD | -1.82% |
| 2004 Q1 | 16.78 Million USD | -1.77% |
| 2004 Q4 | 15.85 Million USD | -1.92% |
| 2003 Q1 | 17.82 Million USD | -1.27% |
| 2003 FY | 17.08 Million USD | -5.34% |
| 2003 Q4 | 17.08 Million USD | -1.72% |
| 2003 Q3 | 17.38 Million USD | -1.15% |
| 2003 Q2 | 17.58 Million USD | -1.32% |
| 2002 Q2 | 18.5 Million USD | -1.18% |
| 2002 FY | 18.05 Million USD | -4.67% |
| 2002 Q4 | 18.05 Million USD | -1.23% |
| 2002 Q3 | 18.27 Million USD | -1.23% |
| 2002 Q1 | 18.72 Million USD | -1.12% |
| 2001 Q4 | 18.93 Million USD | -1.09% |
| 2001 Q3 | 19.14 Million USD | -1.1% |
| 2001 Q1 | 19.56 Million USD | -1.0% |
| 2001 Q2 | 19.35 Million USD | -1.05% |
| 2001 FY | 18.93 Million USD | -4.17% |
| 2000 Q3 | 19.95 Million USD | -0.73% |
| 2000 Q1 | 20.4 Million USD | 0.0% |
| 2000 FY | 19.75 Million USD | 0.0% |
| 2000 Q4 | 19.75 Million USD | -0.97% |
| 2000 Q2 | 20.1 Million USD | -1.47% |
| 1999 Q3 | - USD | 0.0% |
| 1999 Q4 | - USD | 0.0% |
| 1999 Q2 | - USD | 0.0% |
| 1999 Q1 | - USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| 1998 Q4 | - USD | 0.0% |
| 1998 Q3 | - USD | 0.0% |
| 1998 Q2 | - USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| 1998 Q1 | - USD | 0.0% |
| 1997 Q2 | - USD | 0.0% |
| 1997 FY | - USD | 0.0% |
| 1997 Q4 | - USD | 0.0% |
| 1997 Q1 | - USD | 0.0% |
| 1997 Q3 | - USD | 0.0% |
| 1996 Q4 | - USD | 0.0% |
| 1996 FY | - USD | 0.0% |
| 1996 Q3 | - USD | 0.0% |
| 1996 Q2 | - USD | 0.0% |
| 1996 Q1 | - USD | 0.0% |
| 1995 Q1 | - USD | 0.0% |
| 1995 FY | - USD | 0.0% |
| 1995 Q4 | - USD | 0.0% |
| 1995 Q3 | - USD | 0.0% |
| 1995 Q2 | - USD | 0.0% |
| 1994 Q4 | - USD | 0.0% |
| 1994 Q1 | - USD | 0.0% |
| 1994 Q2 | - USD | 0.0% |
| 1994 Q3 | - USD | 0.0% |
| 1994 FY | - USD | 0.0% |
| 1993 FY | - USD | -100.0% |
| 1993 Q2 | 100 Thousand USD | -95.24% |
| 1993 Q3 | - USD | -100.0% |
| 1993 Q4 | - USD | 0.0% |
| 1993 Q1 | 2.1 Million USD | 0.0% |
| 1992 Q4 | 2.1 Million USD | -16.0% |
| 1992 FY | 2.1 Million USD | 162.5% |
| 1992 Q1 | 2.8 Million USD | 250.0% |
| 1992 Q2 | 2.6 Million USD | -7.14% |
| 1992 Q3 | 2.5 Million USD | -3.85% |
| 1991 Q4 | 800 Thousand USD | -27.27% |
| 1991 Q3 | 1.1 Million USD | 10.0% |
| 1991 Q2 | 1 Million USD | 0.0% |
| 1991 Q1 | 1 Million USD | -9.09% |
| 1991 FY | 800 Thousand USD | -27.27% |
| 1990 FY | 1.1 Million USD | 83.33% |
| 1990 Q4 | 1.1 Million USD | -8.33% |
| 1990 Q3 | 1.2 Million USD | 0.0% |
| 1990 Q2 | 1.2 Million USD | 33.33% |
| 1990 Q1 | 900 Thousand USD | 0.0% |
| 1989 FY | 600 Thousand USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Agenus Inc. | 350.24 Million USD | -19.784% |
| Madrigal Pharmaceuticals, Inc. | 117.19 Million USD | -257.989% |
| Entrada Therapeutics, Inc. | 68.23 Million USD | -514.888% |
| Acelyrin, Inc. | 1.19 Million USD | -35037.186% |
| Xeris Biopharma Holdings, Inc. | 229.19 Million USD | -83.052% |
| Verrica Pharmaceuticals Inc. | 45.51 Million USD | -821.859% |
| VistaGen Therapeutics, Inc. | 2.12 Million USD | -19689.528% |
| IO Biotech, Inc. | 2.49 Million USD | -16721.893% |
| Ardelyx, Inc. | 55.98 Million USD | -649.416% |
| Geron Corporation | 85.89 Million USD | -388.408% |
| HOOKIPA Pharma Inc. | 6.55 Million USD | -6296.371% |
| Innoviva, Inc. | 449.07 Million USD | 6.578% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| ChromaDex Corporation | 3.27 Million USD | -12702.502% |
| Ligand Pharmaceuticals Incorporated | 6.16 Million USD | -6705.158% |
| Onconetix, Inc. | 9.88 Million USD | -4143.857% |
| Oncternal Therapeutics, Inc. | 318 Thousand USD | -131830.189% |
| GlycoMimetics, Inc. | 808.4 Thousand USD | -51797.2% |
| IDEAYA Biosciences, Inc. | 2.87 Million USD | -14507.869% |
| Vaxcyte, Inc. | 29.22 Million USD | -1335.594% |
| Pharming Group N.V. | 171.54 Million USD | -144.564% |
| ContextLogic Inc. | 6 Million USD | -6892.3% |
| TRACON Pharmaceuticals, Inc. | 968 Thousand USD | -43240.702% |
| Pyxis Oncology, Inc. | 21.33 Million USD | -1866.799% |
| AlloVir, Inc. | 27.42 Million USD | -1429.542% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 110.35 Million USD | -280.161% |
| Salarius Pharmaceuticals, Inc. | 289.64 Thousand USD | -144746.587% |
| Summit Therapeutics Inc. | 106.09 Million USD | -295.421% |
| Sensei Biotherapeutics, Inc. | 6.2 Million USD | -6658.022% |
| Senti Biosciences, Inc. | 37.66 Million USD | -1013.837% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Psyence Biomedical Ltd. | 7.65 Million USD | -5378.859% |
| Outlook Therapeutics, Inc. | 35.55 Million USD | -1079.96% |
| PDS Biotechnology Corporation | 23.85 Million USD | -1658.95% |
| Windtree Therapeutics, Inc. | 16.83 Million USD | -2392.799% |
| Wave Life Sciences Ltd. | 32.11 Million USD | -1206.239% |
| Phathom Pharmaceuticals, Inc. | 139.03 Million USD | -201.761% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 28.54 Million USD | -1369.948% |
| Elevation Oncology, Inc. | 30.13 Million USD | -1292.103% |
| Akebia Therapeutics, Inc. | 104.18 Million USD | -302.697% |
| Telomir Pharmaceuticals, Inc. Common Stock | 101 Thousand USD | -415284.158% |
| AbCellera Biologics Inc. | 77.38 Million USD | -442.179% |
| TransCode Therapeutics, Inc. | 450.57 Thousand USD | -93012.517% |
| Sangamo Therapeutics, Inc. | 38.1 Million USD | -1001.034% |
| SELLAS Life Sciences Group, Inc. | 906 Thousand USD | -46206.623% |
| Barinthus Biotherapeutics plc | 12.97 Million USD | -3133.185% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Aadi Bioscience, Inc. | 7.02 Million USD | -5872.921% |
| ESSA Pharma Inc. | 80.32 Thousand USD | -522181.147% |
| Vaxxinity, Inc. | 15.16 Million USD | -2665.941% |
| Sol-Gel Technologies Ltd. | 1.65 Million USD | -25280.399% |
| Structure Therapeutics Inc. | 5.45 Million USD | -7593.708% |
| Longboard Pharmaceuticals, Inc. | 475 Thousand USD | -88223.789% |
| Stoke Therapeutics, Inc. | 6.83 Million USD | -6038.083% |
| Lantern Pharma Inc. | 234.47 Thousand USD | -178829.59% |
| VYNE Therapeutics Inc. | 214 Thousand USD | -195945.794% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Opthea Limited | 200.62 Million USD | -109.112% |
| Avidity Biosciences, Inc. | 9.85 Million USD | -4158.404% |
| Syros Pharmaceuticals, Inc. | 62.07 Million USD | -575.857% |
| eFFECTOR Therapeutics, Inc. | 19.44 Million USD | -2057.562% |
| Molecular Templates, Inc. | 12.23 Million USD | -3330.401% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| Sorrento Therapeutics, Inc. | 134.5 Million USD | -211.915% |
| Viracta Therapeutics, Inc. | 25.55 Million USD | -1541.642% |
| Inhibrx Biosciences, Inc. | 210.14 Million USD | -99.646% |
| Orchestra BioMed Holdings, Inc. | 1.68 Million USD | -24768.88% |
| ADMA Biologics, Inc. | 141.41 Million USD | -196.665% |
| Alkermes plc | 290.73 Million USD | -44.305% |
| Alnylam Pharmaceuticals, Inc. | 2.68 Billion USD | 84.361% |
| Alzamend Neuro, Inc. | 300.71 Thousand USD | -139413.957% |
| AnaptysBio, Inc. | 17.81 Million USD | -2255.103% |
| Aptorum Group Limited | 3.36 Million USD | -12377.349% |
| Arrowhead Pharmaceuticals, Inc. | 115.17 Million USD | -264.274% |
| Bicycle Therapeutics plc | 44.95 Million USD | -833.219% |
| BioXcel Therapeutics, Inc. | 101.38 Million USD | -313.811% |
| C4 Therapeutics, Inc. | 70.97 Million USD | -491.098% |
| Clearside Biomedical, Inc. | 43 Million USD | -875.647% |
| Compass Therapeutics, Inc. | 1.73 Million USD | -24108.771% |
| Chimerix, Inc. | 2.14 Million USD | -19468.004% |
| Catalyst Pharmaceuticals, Inc. | 3.55 Million USD | -11694.715% |
| Corbus Pharmaceuticals Holdings, Inc. | 20.88 Million USD | -1908.874% |
| Caribou Biosciences, Inc. | 27.48 Million USD | -1426.425% |
| CRISPR Therapeutics AG | 238.63 Million USD | -75.81% |
| Precision BioSciences, Inc. | 31.26 Million USD | -1241.749% |
| Dyadic International, Inc. | 136.92 Thousand USD | -306290.903% |
| Eton Pharmaceuticals, Inc. | 5.45 Million USD | -7590.889% |
| Fate Therapeutics, Inc. | 103.53 Million USD | -305.21% |
| Fortress Biotech, Inc. | 88.59 Million USD | -373.562% |
| Fortress Biotech, Inc. | 88.59 Million USD | -373.562% |
| GT Biopharma, Inc. | 58 Thousand USD | -723241.379% |
| Hoth Therapeutics, Inc. | 55.16 Thousand USD | -760414.819% |
| ImmuCell Corporation | 11.96 Million USD | -3405.116% |
| Inhibikase Therapeutics, Inc. | 622 Thousand USD | -67349.514% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Incyte Corporation | 38.28 Million USD | -995.771% |
| Intensity Therapeutics, Inc. | 158 Thousand USD | -265430.38% |
| Jaguar Health, Inc. | 35.86 Million USD | -1069.933% |
| Janux Therapeutics, Inc. | 24.54 Million USD | -1609.469% |
| Keros Therapeutics, Inc. | 14.44 Million USD | -2804.583% |
| MiMedx Group, Inc. | 48.09 Million USD | -772.239% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| Mesoblast Limited | 118.92 Million USD | -252.781% |
| Novavax, Inc. | 280.63 Million USD | -49.496% |
| NextCure, Inc. | 6.6 Million USD | -6251.824% |
| Precigen, Inc. | 7.09 Million USD | -5811.484% |
| PureTech Health plc | 25.51 Million USD | -1544.473% |
| Rigel Pharmaceuticals, Inc. | 60.57 Million USD | -592.547% |
| Seer, Inc. | 28.25 Million USD | -1384.617% |
| Syndax Pharmaceuticals, Inc. | 1.63 Million USD | -25559.817% |
| Rocket Pharmaceuticals, Inc. | 25.04 Million USD | -1575.337% |
| Aptose Biosciences Inc. | 1 Million USD | -41446.396% |
| ZyVersa Therapeutics, Inc. | 8656.00 USD | -4846688.355% |
| Soligenix, Inc. | 3.49 Million USD | -11905.456% |
| Century Therapeutics, Inc. | 48.17 Million USD | -770.935% |
| Kura Oncology, Inc. | 17.2 Million USD | -2339.174% |
| TScan Therapeutics, Inc. | 92.43 Million USD | -353.883% |
| Ocean Biomedical, Inc. | 2.15 Million USD | -19413.395% |
| CytomX Therapeutics, Inc. | 13.97 Million USD | -2902.276% |
| Autolus Therapeutics plc | 52.96 Million USD | -692.074% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 5.46 Million USD | -7571.201% |
| Eterna Therapeutics Inc. | 41.84 Million USD | -902.648% |
| Adaptive Biotechnologies Corporation | 229.43 Million USD | -82.859% |
| GRI Bio, Inc. | 14 Thousand USD | -2996600.0% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Tenaya Therapeutics, Inc. | 12.42 Million USD | -3276.835% |
| IGM Biosciences, Inc. | 40.5 Million USD | -935.743% |
| INmune Bio, Inc. | 10.43 Million USD | -3919.718% |
| Heron Therapeutics, Inc. | 179.62 Million USD | -133.559% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -7002.316% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -513536.141% |
| Entero Therapeutics, Inc. | 826.84 Thousand USD | -50639.68% |
| Milestone Pharmaceuticals Inc. | 51.77 Million USD | -710.31% |
| X4 Pharmaceuticals, Inc. | 58.28 Million USD | -619.854% |
| Atara Biotherapeutics, Inc. | 57.87 Million USD | -624.941% |
| Coherus BioSciences, Inc. | 480.84 Million USD | 12.749% |
| Verastem, Inc. | 41.55 Million USD | -909.548% |
| Abeona Therapeutics Inc. | 5.4 Million USD | -7669.222% |
| Pliant Therapeutics, Inc. | 11.37 Million USD | -3589.219% |
| Tonix Pharmaceuticals Holding Corp. | 9.81 Million USD | -4175.329% |
| Histogen Inc. | 4.62 Million USD | -8976.98% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Surrozen, Inc. | 3.37 Million USD | -12316.04% |
| Organovo Holdings, Inc. | 1.39 Million USD | -29995.983% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 46 Million USD | -812.005% |
| Panbela Therapeutics, Inc. | 5.19 Million USD | -7977.358% |
| CASI Pharmaceuticals, Inc. | 21.23 Million USD | -1875.319% |
| Cadrenal Therapeutics, Inc. Common Stock | 21.35 Thousand USD | -1964949.18% |
| Centessa Pharmaceuticals plc | 84.58 Million USD | -395.978% |
| Hepion Pharmaceuticals, Inc. | 209.02 Thousand USD | -200616.678% |
| Arcturus Therapeutics Holdings Inc. | 30.21 Million USD | -1288.463% |
| BioRestorative Therapies, Inc. | 162.31 Thousand USD | -258368.306% |
| Apollomics, Inc. | 4.66 Million USD | -8901.03% |
| Amarin Corporation plc | 8.73 Million USD | -4701.854% |
| Turnstone Biologics Corp. | 3.21 Million USD | -12953.454% |
| Kymera Therapeutics, Inc. | 84.67 Million USD | -395.474% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 247 Thousand USD | -169753.441% |
| Aurinia Pharmaceuticals Inc. | 97.6 Million USD | -329.824% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 189.94 Million USD | -120.875% |
| Better Therapeutics, Inc. | 14.88 Million USD | -2719.476% |
| Nurix Therapeutics, Inc. | 30.61 Million USD | -1270.412% |
| Apellis Pharmaceuticals, Inc. | 110.92 Million USD | -278.207% |
| NLS Pharmaceutics AG | 1.63 Million USD | -25579.512% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | 6.13 Million USD | -6744.013% |
| Gritstone bio, Inc. | 104.77 Million USD | -300.418% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -14958.794% |
| TNF Pharmaceuticals, Inc. | 48.87 Thousand USD | -858377.594% |
| Avid Bioservices, Inc. | 207.83 Million USD | -101.862% |
| Insmed Incorporated | 1.2 Billion USD | 65.154% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 6.71 Million USD | -6151.498% |
| OmniAb, Inc. | 25.56 Million USD | -1541.321% |
| Alector, Inc. | 38.91 Million USD | -978.005% |
| Seres Therapeutics, Inc. | 213.93 Million USD | -96.104% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Zai Lab Limited | 15.15 Million USD | -2669.045% |
| Revance Therapeutics, Inc. | 478.43 Million USD | 12.31% |
| Aura Biosciences, Inc. | 19.55 Million USD | -2045.206% |
| Lyell Immunopharma, Inc. | 63.16 Million USD | -564.173% |
| Immunic, Inc. | 1.33 Million USD | -31349.625% |
| Tarsus Pharmaceuticals, Inc. | 31.73 Million USD | -1222.129% |
| Veracyte, Inc. | 12.63 Million USD | -3221.758% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 34.942% |
| FibroGen, Inc. | 170.45 Million USD | -146.128% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -4519.954% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 203.91 Thousand USD | -205645.644% |
| Jazz Pharmaceuticals plc | 5.79 Billion USD | 92.762% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -1133786.486% |
| Amylyx Pharmaceuticals, Inc. | 4.23 Million USD | -9801.77% |
| TG Therapeutics, Inc. | 110.79 Million USD | -278.661% |
| Galecto, Inc. | 249 Thousand USD | -168389.157% |
| Calithera Biosciences, Inc. | 1.66 Million USD | -25082.353% |
| Fortrea Holdings Inc. | 1.67 Billion USD | 74.998% |
| KalVista Pharmaceuticals, Inc. | 7.31 Million USD | -5633.743% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -7673.541% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -14958.794% |
| Lyra Therapeutics, Inc. | 26.88 Million USD | -1460.723% |
| Foghorn Therapeutics Inc. | 45.07 Million USD | -830.797% |
| Y-mAbs Therapeutics, Inc. | 1.41 Million USD | -29465.751% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -827.443% |
| Ultragenyx Pharmaceutical Inc. | 43.16 Million USD | -871.85% |
| Metagenomi, Inc. Common Stock | 48.22 Million USD | -769.887% |
| BioCryst Pharmaceuticals, Inc. | 848.71 Million USD | 50.568% |
| Gain Therapeutics, Inc. | 1.02 Million USD | -40735.003% |
| Cartesian Therapeutics, Inc. | 10.95 Million USD | -3729.649% |
| NexImmune, Inc. | 68.8 Thousand USD | -609613.846% |
| Creative Medical Technology Holdings, Inc. | 14.19 Thousand USD | -2955641.863% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 84.478% |
| Chemomab Therapeutics Ltd. | 392 Thousand USD | -106924.454% |
| RAPT Therapeutics, Inc. | 6.9 Million USD | -5974.978% |
| Ainos, Inc. | 5.96 Million USD | -6935.031% |
| Pluri Inc. | 29.61 Million USD | -1316.784% |
| Prothena Corporation plc | 11.83 Million USD | -3444.892% |
| Adaptimmune Therapeutics plc | 25.23 Million USD | -1562.524% |
| Celularity Inc. | 65.41 Million USD | -541.329% |
| Rallybio Corporation | 392 Thousand USD | -106925.0% |
| Cue Biopharma, Inc. | 14.69 Million USD | -2754.971% |
| MeiraGTx Holdings plc | 89.26 Million USD | -369.997% |
| Omeros Corporation | 338.28 Million USD | -24.021% |
| Humacyte, Inc. | 58.1 Million USD | -622.022% |
| Immunocore Holdings plc | 84.03 Million USD | -399.26% |
| Cocrystal Pharma, Inc. | 1.85 Million USD | -22541.015% |
| Cidara Therapeutics, Inc. | 4.87 Million USD | -8502.379% |
| Blueprint Medicines Corporation | 774.12 Million USD | 45.805% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | 5.01 Million USD | -8260.662% |
| Scholar Rock Holding Corporation | 61.81 Million USD | -578.666% |
| Sana Biotechnology, Inc. | 104.09 Million USD | -303.03% |
| Pulmatrix, Inc. | 8.75 Million USD | -4691.434% |
| Elicio Therapeutics, Inc. | 6.91 Million USD | -5965.317% |
| Vigil Neuroscience, Inc. | 13.85 Million USD | -2929.155% |
| Intellia Therapeutics, Inc. | 115.34 Million USD | -263.721% |
| Adlai Nortye Ltd. American Depositary Shares | 31.54 Million USD | -1229.84% |
| Cytokinetics, Incorporated | 755.77 Million USD | 44.489% |
| Eloxx Pharmaceuticals, Inc. | 13.38 Million USD | -3034.623% |
| Nutriband Inc. | 241.28 Thousand USD | -173776.536% |
| Protara Therapeutics, Inc. | 5.46 Million USD | -7574.008% |
| Vor Biopharma Inc. | 35.66 Million USD | -1076.495% |
| Roivant Sciences Ltd. | 499.74 Million USD | 16.05% |
| Evogene Ltd. | 1.13 Million USD | -36766.257% |
| ProKidney Corp. | 4.41 Million USD | -9406.866% |
| Applied Therapeutics, Inc. | 1.22 Million USD | -34120.065% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 75.886% |
| CorMedix Inc. | 667.63 Thousand USD | -62739.708% |
| BioLineRx Ltd. | 11.59 Million USD | -3519.515% |
| Tango Therapeutics, Inc. | 38.92 Million USD | -977.95% |
| Galectin Therapeutics Inc. | 71.8 Million USD | -484.258% |
| Atai Life Sciences N.V. | 16.47 Million USD | -2446.358% |
| Renovaro Biosciences Inc. | 2.45 Million USD | -17017.041% |
| Aerovate Therapeutics, Inc. | 675 Thousand USD | -62053.778% |
| Zentalis Pharmaceuticals, Inc. | 45.77 Million USD | -816.562% |
| Sagimet Biosciences Inc. | 65 Thousand USD | -645343.077% |
| MediciNova, Inc. | 215.92 Thousand USD | -194197.12% |
| Praxis Precision Medicines, Inc. | 2.49 Million USD | -16715.15% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -33169.523% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 186.37 Million USD | -125.108% |
| Biomea Fusion, Inc. | 10.29 Million USD | -3974.767% |
| PTC Therapeutics, Inc. | 415.02 Million USD | -1.087% |
| Mereo BioPharma Group plc | 5.95 Million USD | -6948.69% |
| Cullinan Oncology, Inc. | 3.59 Million USD | -11586.295% |
| Absci Corporation | 15.95 Million USD | -2529.178% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -4479.609% |
| 4D Molecular Therapeutics, Inc. | 14.67 Million USD | -2759.641% |
| Dyne Therapeutics, Inc. | 27.41 Million USD | -1430.323% |
| Kiniksa Pharmaceuticals, Ltd. | 12.25 Million USD | -3322.565% |
| Ventyx Biosciences, Inc. | 12.5 Million USD | -3254.694% |
| Allakos Inc. | 41.46 Million USD | -911.788% |
| Imunon, Inc. | 1.62 Million USD | -25722.268% |
| Fulcrum Therapeutics, Inc. | 10.82 Million USD | -3777.072% |
| Corcept Therapeutics Incorporated | 151 Thousand USD | -277739.735% |
| BioAtla, Inc. | 2.46 Million USD | -16954.39% |
| NLS Pharmaceutics AG | 1.63 Million USD | -25579.512% |
| Bio-Path Holdings, Inc. | 113 Thousand USD | -371172.566% |
| Allogene Therapeutics, Inc. | 95.12 Million USD | -341.057% |
| Larimar Therapeutics, Inc. | 5.54 Million USD | -7464.695% |
| XOMA Corporation | 124.45 Million USD | -237.114% |
| Kezar Life Sciences, Inc. | 18.93 Million USD | -2115.909% |
| Cara Therapeutics, Inc. | 43.16 Million USD | -871.895% |
| aTyr Pharma, Inc. | 15.09 Million USD | -2679.318% |
| Aligos Therapeutics, Inc. | 11.13 Million USD | -3666.727% |
| Akero Therapeutics, Inc. | 26.04 Million USD | -1510.943% |
| Viridian Therapeutics, Inc. | 21.04 Million USD | -1893.244% |
| Eliem Therapeutics, Inc. | 349 Thousand USD | -120111.461% |
| EyeGate Pharmaceuticals, Inc. | 326.49 Thousand USD | -128398.314% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -25611.318% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 72.017% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -255767.339% |
| UroGen Pharma Ltd. | 100.21 Million USD | -318.642% |
| Sutro Biopharma, Inc. | 182.74 Million USD | -129.571% |
| ZIVO Bioscience, Inc. | 346.34 Thousand USD | -121034.024% |
| Orgenesis Inc. | 22.62 Million USD | -1754.639% |
| Entera Bio Ltd. | 390 Thousand USD | -107473.846% |
| GH Research PLC | 343 Thousand USD | -122214.286% |
| Lisata Therapeutics, Inc. | 305 Thousand USD | -137453.443% |
| Reneo Pharmaceuticals, Inc. | 973 Thousand USD | -43017.986% |
| Xencor, Inc. | 83.43 Million USD | -402.838% |
| 60 Degrees Pharmaceuticals, Inc. | 172.67 Thousand USD | -242866.764% |
| Replimune Group, Inc. | 75.86 Million USD | -452.977% |
| Coeptis Therapeutics Holdings, Inc. | 1.22 Million USD | -34169.653% |
| Vanda Pharmaceuticals Inc. | 9.4 Million USD | -4361.272% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -255767.339% |
| Portage Biotech Inc. | 47 Thousand USD | -892534.043% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -33169.523% |
| Olema Pharmaceuticals, Inc. | 2.41 Million USD | -17257.799% |
| OncoCyte Corporation | 2.86 Million USD | -14523.144% |
| Qualigen Therapeutics, Inc. | 1.29 Million USD | -32191.628% |
| Processa Pharmaceuticals, Inc. | 150.55 Thousand USD | -278562.805% |
| Purple Biotech Ltd. | 351 Thousand USD | -119426.496% |
| CollPlant Biotechnologies Ltd. | 3.15 Million USD | -13180.722% |
| scPharmaceuticals Inc. | 40.26 Million USD | -941.839% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| HilleVax, Inc. | 51.19 Million USD | -719.522% |
| NeuroSense Therapeutics Ltd. | 142 Thousand USD | -295349.296% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | 5.23 Million USD | -7920.226% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.73 Million USD | -1469.07% |
| Curis, Inc. | 2.79 Million USD | -14915.676% |
| Daré Bioscience, Inc. | 5.31 Million USD | -7788.803% |
| Carmell Therapeutics Corporation | 2.13 Million USD | -19537.164% |
| Titan Pharmaceuticals, Inc. | 565 Thousand USD | -74154.513% |
| Achieve Life Sciences, Inc. | 16.73 Million USD | -2407.549% |
| BeiGene, Ltd. | 930.18 Million USD | 54.897% |
| Kiromic BioPharma, Inc. | 15.54 Million USD | -2599.295% |
| Revolution Medicines, Inc. Warrant | 87.94 Million USD | -377.051% |
| Protagonist Therapeutics, Inc. | 1.14 Million USD | -36669.325% |
| Erasca, Inc. | 55.85 Million USD | -651.066% |
| bluebird bio, Inc. | 330.32 Million USD | -27.007% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 1.13 Billion USD | 63.0% |
| DBV Technologies S.A. | 14.38 Million USD | -2817.308% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 2.5 Million USD | -16668.106% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Acrivon Therapeutics, Inc. Common Stock | 4.64 Million USD | -8933.979% |
| Travere Therapeutics, Inc. | 404.78 Million USD | -3.645% |
| Monte Rosa Therapeutics, Inc. | 46.03 Million USD | -811.267% |
| Spruce Biosciences, Inc. | 4.6 Million USD | -9002.582% |
| Celldex Therapeutics, Inc. | 2.54 Million USD | -16404.249% |
| Cogent Biosciences, Inc. | 18.85 Million USD | -2125.312% |
| MacroGenics, Inc. | 33.97 Million USD | -1134.989% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | 20.92 Million USD | -1905.056% |
| Prime Medicine, Inc. | 13.63 Million USD | -2977.371% |
| Aditxt, Inc. | 18.21 Million USD | -2202.878% |
| Adagene Inc. | 22.3 Million USD | -1780.757% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 15.3 Million USD | -2641.541% |
| Maravai LifeSciences Holdings, Inc. | 610.96 Million USD | 31.332% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 20.29 Million USD | -1967.403% |
| SciSparc Ltd. | 76 Thousand USD | -551923.684% |
| Vericel Corporation | 88.14 Million USD | -375.974% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -411.527% |
| Generation Bio Co. | 97.89 Million USD | -328.564% |
| Astria Therapeutics, Inc. | 329 Thousand USD | -127419.149% |
| Black Diamond Therapeutics, Inc. | 25.29 Million USD | -1558.384% |
| Arcutis Biotherapeutics, Inc. | 205.91 Million USD | -103.742% |
| Invivyd, Inc. | 2.16 Million USD | -19278.199% |
| Relay Therapeutics, Inc. | 53.46 Million USD | -684.682% |
| Quoin Pharmaceuticals, Ltd. | 3523.73 USD | -11905976.799% |
| Spero Therapeutics, Inc. | 5.54 Million USD | -7468.789% |
| Artelo Biosciences, Inc. | 63 Thousand USD | -665833.333% |
| 2seventy bio, Inc. | 256.67 Million USD | -63.452% |
| Clene Inc. | 32.16 Million USD | -1204.493% |
| Capricor Therapeutics, Inc. | 5.61 Million USD | -7375.525% |
| Boundless Bio, Inc. Common Stock | 2.19 Million USD | -19013.349% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Recursion Pharmaceuticals, Inc. | 50.67 Million USD | -727.948% |
| Citius Pharmaceuticals, Inc. | 481.24 Thousand USD | -87077.633% |
| Contineum Therapeutics, Inc. Class A Common Stock | 193.19 Million USD | -117.161% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | 30.12 Million USD | -1292.611% |
| ALX Oncology Holdings Inc. | 17.19 Million USD | -2339.6% |
| Vir Biotechnology, Inc. | 124.54 Million USD | -236.87% |
| Evaxion Biotech A/S | 10.86 Million USD | -3759.709% |
| Ocular Therapeutix, Inc. | 83.38 Million USD | -403.11% |
| Verve Therapeutics, Inc. | 74.9 Million USD | -460.078% |
| Trevena, Inc. | 35.23 Million USD | -1090.753% |
| Surrozen, Inc. | 3.37 Million USD | -12316.04% |
| Tyra Biosciences, Inc. | 6.49 Million USD | -6358.405% |
| Cingulate Inc. | 3.13 Million USD | -13281.97% |
| Galmed Pharmaceuticals Ltd. | 41 Thousand USD | -1023163.415% |
| Unity Biotechnology, Inc. | 26.99 Million USD | -1454.42% |
| Tenax Therapeutics, Inc. | 500.9 Thousand USD | -83656.336% |
| Terns Pharmaceuticals, Inc. | 603 Thousand USD | -69475.124% |
| ACADIA Pharmaceuticals Inc. | 57.2 Million USD | -633.394% |
| Connect Biopharma Holdings Limited | 465 Thousand USD | -90123.226% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 28.27 Million USD | -1383.935% |
| Bolt Biotherapeutics, Inc. | 20.21 Million USD | -1974.969% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -26879.936% |
| Viking Therapeutics, Inc. | 1.26 Million USD | -33196.667% |
| Statera Biopharma, Inc. | 16.26 Million USD | -2480.004% |
| ImmunityBio, Inc. | 883.67 Million USD | 52.524% |
| Korro Bio, Inc. | 33.2 Million USD | -1163.402% |
| Kineta, Inc. | 1.31 Million USD | -31755.581% |
| BioVie Inc. | 6.11 Million USD | -6764.79% |
| Codexis, Inc. | 22.36 Million USD | -1775.952% |
| Celularity Inc. | 65.41 Million USD | -541.329% |
| Crinetics Pharmaceuticals, Inc. | 51.72 Million USD | -711.046% |
| Celcuity Inc. | 37.44 Million USD | -1020.373% |
| Virax Biolabs Group Limited | 224.3 Thousand USD | -186943.246% |
| Cibus, Inc. | 24.62 Million USD | -1603.984% |
| Eledon Pharmaceuticals, Inc. | 383 Thousand USD | -109439.948% |
| IN8bio, Inc. | 4.89 Million USD | -8474.249% |
| Kodiak Sciences Inc. | 181.63 Million USD | -130.982% |
| Annexon, Inc. | 31.35 Million USD | -1238.026% |
| Adverum Biotechnologies, Inc. | 75.03 Million USD | -459.116% |
| Assembly Biosciences, Inc. | 2.34 Million USD | -17813.664% |
| Avalo Therapeutics, Inc. | 3.9 Million USD | -10649.116% |
| Ionis Pharmaceuticals, Inc. | 1.45 Billion USD | 71.137% |
| Eyenovia, Inc. | 16.1 Million USD | -2504.571% |
| Puma Biotechnology, Inc. | 111.49 Million USD | -276.301% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -42492.69% |
| Xilio Therapeutics, Inc. | 11.45 Million USD | -3561.849% |
| Arcellx, Inc. | 97.62 Million USD | -329.744% |
| Cardiff Oncology, Inc. | 2.14 Million USD | -19422.476% |
| Enanta Pharmaceuticals, Inc. | 26.51 Million USD | -1482.386% |
| Regulus Therapeutics Inc. | 3.1 Million USD | -13424.758% |
| Moolec Science SA | 2.64 Million USD | -15759.817% |
| Acumen Pharmaceuticals, Inc. | 28.48 Million USD | -1372.735% |
| LAVA Therapeutics N.V. | 6.31 Million USD | -6545.62% |
| Royalty Pharma plc | 6.13 Billion USD | 93.162% |
| Atea Pharmaceuticals, Inc. | 2.4 Million USD | -17366.195% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 115.25 Thousand USD | -363911.661% |
| Mersana Therapeutics, Inc. | 33.83 Million USD | -1140.136% |
| Humacyte, Inc. | 58.1 Million USD | -622.022% |
| 89bio, Inc. | 27.1 Million USD | -1447.654% |
| PMV Pharmaceuticals, Inc. | 13.28 Million USD | -3057.745% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 2.51 Million USD | -16554.942% |
| Trevi Therapeutics, Inc. | 1.33 Million USD | -31255.605% |
| Lexicon Pharmaceuticals, Inc. | 106.06 Million USD | -295.552% |
| Notable Labs, Ltd. | 2.04 Million USD | -20375.256% |
| Liquidia Corporation | 3.5 Million USD | -11876.534% |
| Mustang Bio, Inc. | 2.49 Million USD | -16694.956% |
| Immunovant, Inc. | 138 Thousand USD | -303913.043% |
| Quantum-Si incorporated | 15.3 Million USD | -2641.541% |
| Arbutus Biopharma Corporation | 8.72 Million USD | -4710.664% |
| DiaMedica Therapeutics Inc. | 400 Thousand USD | -104784.5% |
| Vera Therapeutics, Inc. | 53.7 Million USD | -681.146% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -513536.141% |
| Xenon Pharmaceuticals Inc. | 10.9 Million USD | -3747.913% |
| Elevai Labs, Inc. Common Stock | 210.48 Thousand USD | -199215.879% |
| NeuroBo Pharmaceuticals, Inc. | 203 Thousand USD | -206568.966% |
| Tempest Therapeutics, Inc. | 20.66 Million USD | -1930.579% |
| Soleno Therapeutics, Inc. | 403 Thousand USD | -104003.722% |
| PepGen Inc. | 20.1 Million USD | -1986.838% |
| Moleculin Biotech, Inc. | 574 Thousand USD | -72990.244% |
| United Therapeutics Corporation | 700 Million USD | 40.066% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Solid Biosciences Inc. | 26.26 Million USD | -1497.327% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | 4.46 Million USD | -9300.445% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | 886 Thousand USD | -47251.919% |
| XOMA Corporation | 124.45 Million USD | -237.114% |
| ARS Pharmaceuticals, Inc. | 274 Thousand USD | -153016.058% |
| Bionomics Limited | 239.61 Million USD | -75.086% |
| Apogee Therapeutics, Inc. | 2.03 Million USD | -20526.264% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -3060.124% |
| uniQure N.V. | 138.4 Million USD | -203.115% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 85.42 Million USD | -391.13% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 1.03 Million USD | -40552.907% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -42492.69% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -4519.954% |
| FibroBiologics, Inc. Common Stock | 1.74 Million USD | -23914.768% |
| Altimmune, Inc. | 671 Thousand USD | -62424.292% |
| Amicus Therapeutics, Inc. | 445.05 Million USD | 5.734% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -3060.124% |
| Compugen Ltd. | 1.35 Million USD | -30953.886% |
| Peak Bio, Inc. | 10.72 Million USD | -3812.941% |
| Zevra Therapeutics, Inc. | 42.76 Million USD | -881.008% |
| Benitec Biopharma Inc. | 284 Thousand USD | -147624.648% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -396.172% |
| NKGen Biotech, Inc. Common Stock | 19.92 Million USD | -2006.009% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | 11.77 Million USD | -3461.745% |
| Aileron Therapeutics, Inc. | 91.45 Million USD | -358.722% |
| NKGen Biotech, Inc. Warrants | 19.92 Million USD | -2006.009% |
| Instil Bio, Inc. | 86.05 Million USD | -387.529% |
| argenx SE | 20 Million USD | -1997.69% |
| Immunome, Inc. | 1.65 Million USD | -25326.545% |
| Verona Pharma plc | 51.32 Million USD | -717.351% |
| enGene Holdings Inc. Warrants | 9.77 Million USD | -4190.632% |
| Shattuck Labs, Inc. | 4.2 Million USD | -9884.246% |
| CervoMed Inc. | - USD | -Infinity% |
| LENZ Therapeutics, Inc. | 362 Thousand USD | -115794.475% |
| Plus Therapeutics, Inc. | 4.18 Million USD | -9934.394% |
| Dianthus Therapeutics, Inc. | 585 Thousand USD | -71615.897% |
| Moolec Science SA | 2.64 Million USD | -15759.817% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Inovio Pharmaceuticals, Inc. | 30.2 Million USD | -1288.774% |
| Design Therapeutics, Inc. | 3.05 Million USD | -13655.344% |
| Leap Therapeutics, Inc. | 262 Thousand USD | -160029.008% |
| NeurAxis, Inc. | 224.26 Thousand USD | -186976.608% |
| Seelos Therapeutics, Inc. | 14.22 Million USD | -2848.679% |
| Lumos Pharma, Inc. | 6.58 Million USD | -6271.116% |
| Achilles Therapeutics plc | 4.61 Million USD | -8990.748% |
| enGene Holdings Inc. Common Stock | 9.77 Million USD | -4190.632% |
| 180 Life Sciences Corp. | 1.32 Million USD | -31681.521% |
| Opiant Pharmaceuticals, Inc. | 17.08 Million USD | -2356.294% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -26879.936% |
| Nutriband Inc. | 241.28 Thousand USD | -173776.536% |
| ORIC Pharmaceuticals, Inc. | 10.21 Million USD | -4007.882% |
| CG Oncology, Inc. Common stock | 826 Thousand USD | -50691.525% |
| Fractyl Health, Inc. Common Stock | 373.72 Million USD | -12.26% |
| Rani Therapeutics Holdings, Inc. | 30.09 Million USD | -1293.86% |
| MoonLake Immunotherapeutics | 3.69 Million USD | -11245.408% |
| Palisade Bio, Inc. | 369 Thousand USD | -113595.935% |
| Tourmaline Bio, Inc. | 415 Thousand USD | -100993.494% |
| Beam Therapeutics Inc. | 173.17 Million USD | -142.265% |
| Neurogene Inc. | 16.25 Million USD | -2480.978% |
| Mirum Pharmaceuticals, Inc. | 308.14 Million USD | -36.151% |
| AEON Biopharma, Inc. | 278 Thousand USD | -150812.95% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Enliven Therapeutics, Inc. | 335 Thousand USD | -125135.224% |
| Kiora Pharmaceuticals, Inc. | 106.89 Thousand USD | -392391.416% |
| Iovance Biotherapeutics, Inc. | 75.86 Million USD | -453.028% |
| Taysha Gene Therapies, Inc. | 61.1 Million USD | -586.563% |
| Athira Pharma, Inc. | 1.58 Million USD | -26369.274% |
| Vaccinex, Inc. | 247 Thousand USD | -169753.441% |
| HCW Biologics Inc. | 6.45 Million USD | -6402.674% |
| XOMA Corporation | 124.45 Million USD | -237.114% |
| Nektar Therapeutics | 230.4 Million USD | -82.09% |
| Arvinas, Inc. | 3.4 Million USD | -12239.353% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -25611.318% |
| Merus N.V. | 12.16 Million USD | -3349.581% |
| Omega Therapeutics, Inc. | 128.42 Million USD | -226.672% |
| Quince Therapeutics, Inc. | 13.81 Million USD | -2937.049% |
| Rezolute, Inc. | 2.22 Million USD | -18730.251% |
| Clene Inc. | 32.16 Million USD | -1204.493% |
| Indaptus Therapeutics, Inc. | 175.05 Thousand USD | -239563.416% |
| BeyondSpring Inc. | 3.99 Million USD | -10401.577% |
| Synlogic, Inc. | 17.27 Million USD | -2328.585% |
| Allarity Therapeutics, Inc. | 1.3 Million USD | -32172.154% |
| Phio Pharmaceuticals Corp. | 35 Thousand USD | -1198580.0% |
| Peak Bio, Inc. | 10.72 Million USD | -3812.941% |
| Werewolf Therapeutics, Inc. | 51.92 Million USD | -708.0% |
| Krystal Biotech, Inc. | 8.09 Million USD | -5083.322% |
| Karyopharm Therapeutics Inc. | 177.01 Million USD | -137.006% |
| SpringWorks Therapeutics, Inc. | 7.05 Million USD | -5844.991% |
| Lipella Pharmaceuticals Inc. | 136.59 Thousand USD | -307042.334% |
| MannKind Corporation | 382.37 Million USD | -9.718% |
| Ikena Oncology, Inc. | 10.73 Million USD | -3807.04% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 409 Thousand USD | -102476.528% |
| Gossamer Bio, Inc. | 212.46 Million USD | -97.463% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 174 Thousand USD | -241013.793% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -4479.609% |
| Legend Biotech Corporation | 328.67 Million USD | -27.646% |
| Mural Oncology plc | 15 Million USD | -2695.243% |
| Biora Therapeutics, Inc. | 47.42 Million USD | -784.616% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | 2.1 Million USD | -19868.491% |
| Champions Oncology, Inc. | 7.43 Million USD | -5546.541% |
| REGENXBIO Inc. | 89.29 Million USD | -369.86% |
| Ensysce Biosciences, Inc. | 854.69 Thousand USD | -48986.167% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 552.98 Thousand USD | -75768.292% |
| Edgewise Therapeutics, Inc. | 5.41 Million USD | -7649.132% |
| Vaxart, Inc. | 26.51 Million USD | -1482.326% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 15.65 Million USD | -2579.494% |
| Cellectis S.A. | 92.85 Million USD | -351.83% |
| Longeveron Inc. | 2.04 Million USD | -20455.512% |
| Repare Therapeutics Inc. | 3.41 Million USD | -12203.167% |
| Sarepta Therapeutics, Inc. | 1.39 Billion USD | 69.965% |
| Inozyme Pharma, Inc. | 46.59 Million USD | -800.451% |
| Revolution Medicines, Inc. | 87.94 Million USD | -377.051% |
| Nymox Pharmaceutical Corporation | 173 Thousand USD | -242407.514% |
| Third Harmonic Bio, Inc. | 3.95 Million USD | -10513.155% |
| ArriVent BioPharma, Inc. Common Stock | 317 Thousand USD | -132246.372% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 175 Thousand USD | -239636.0% |
| Vertex Pharmaceuticals Incorporated | 808.4 Million USD | 48.103% |
| Denali Therapeutics Inc. | 52.24 Million USD | -703.082% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 14.4 Million USD | -2812.353% |
| Corvus Pharmaceuticals, Inc. | 1.37 Million USD | -30434.061% |
| Cingulate Inc. | 3.13 Million USD | -13281.97% |
| Passage Bio, Inc. | 26.29 Million USD | -1495.566% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.66 Million USD | -6194.644% |
| Day One Biopharmaceuticals, Inc. | 408 Thousand USD | -102727.941% |
| Oramed Pharmaceuticals Inc. | 894 Thousand USD | -46828.188% |
| Scinai Immunotherapeutics Ltd. | 20.56 Million USD | -1940.455% |
| Rhythm Pharmaceuticals, Inc. | 1.26 Million USD | -33196.667% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 2.45 Million USD | -17016.168% |
| Carisma Therapeutics, Inc. | 3.12 Million USD | -13333.814% |
| Unicycive Therapeutics, Inc. | 811 Thousand USD | -51630.949% |
| OmniAb, Inc. | 25.56 Million USD | -1541.321% |
| Anew Medical, Inc. | 1.6 Million USD | -26039.439% |
| Fennec Pharmaceuticals Inc. | 29.58 Million USD | -1318.179% |
| Lipocine Inc. | 17.16 Thousand USD | -2443905.592% |
| Lexeo Therapeutics, Inc. Common Stock | 11.63 Million USD | -3504.898% |
| Nautilus Biotechnology, Inc. | 34.62 Million USD | -1111.557% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -7002.316% |
| G1 Therapeutics, Inc. | 57.17 Million USD | -633.804% |
| Bellerophon Therapeutics, Inc. | 203 Thousand USD | -206568.966% |
| Sage Therapeutics, Inc. | 5.16 Million USD | -8022.711% |
| Ocugen, Inc. | 6.94 Million USD | -5944.345% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -2869.34% |
| Q32 Bio Inc. | 1.31 Million USD | -31731.411% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -62331.25% |
| Alumis Inc. Common Stock | 32.58 Million USD | -1187.716% |
| Equillium, Inc. | 824 Thousand USD | -50814.806% |
| Kyverna Therapeutics, Inc. | 9.07 Million USD | -4520.971% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | 300.8 Thousand USD | -139371.287% |
| Galera Therapeutics, Inc. | 152.29 Million USD | -175.47% |
| Evelo Biosciences, Inc. | 51.13 Million USD | -720.404% |
| Comera Life Sciences Holdings, Inc. | 775.04 Thousand USD | -54030.583% |
| Dominari Holdings Inc. | 3.02 Million USD | -13755.284% |
| Edesa Biotech, Inc. | 94.48 Thousand USD | -443916.637% |
| vTv Therapeutics Inc. | 529 Thousand USD | -79207.75% |
| Agios Pharmaceuticals, Inc. | 71.99 Million USD | -482.724% |
| Harmony Biosciences Holdings, Inc. | 193.56 Million USD | -116.742% |
| Prelude Therapeutics Incorporated | 16.88 Million USD | -2384.237% |
| Candel Therapeutics, Inc. | 22.76 Million USD | -1743.151% |
| iTeos Therapeutics, Inc. | 6.05 Million USD | -6825.355% |
| Nkarta, Inc. | 88.33 Million USD | -374.918% |
| BioCardia, Inc. | 1.31 Million USD | -31804.03% |
| Iterum Therapeutics plc | 19.5 Million USD | -2050.484% |